Specialized stromal tumors of the prostate: A clinicopathologic study of 50 cases

American Journal of Surgical Pathology

Volumn 30, Issue 6, 2006, Pages 694-704

  Herawi, Mehsati ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Degenerative atypia; Metastasis; Phyllodes tumor; Prostate; Prostatic STUMP; Recurrence; Stromal sarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CYSTOSARCOMA PHYLLOIDES; ENUCLEATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PROGNOSIS; PROSTATE CANCER; STROMA CELL; TUMOR RECURRENCE; TUMOR VOLUME; ADOLESCENT; AGE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SARCOMA; TRANSURETHRAL RESECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SARCOMA; STROMAL CELLS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 33745917069     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200606000-00004     Document Type: Article

References (27)

1. Agrawal V, Sharma D, Wadhwa N. Case report: Malignant phyllodes tumor of prostate. Int Urol Nephrol. 2003;35:37-39.
2. Attah EB, Nkposong EO. Phyllodes type of atypical prostatic hyperplasia. J Urol. 1976;115:762-764.
3. Attah EB, Powell ME. Atypical stromal hyperplasia of the prostate gland. Am J Clin Pathol. 1977;67:324-327.
4. Bierhoff E, Vogel J, Benz M, et al. Stromal nodules in benign prostatic hyperplasia. Eur Urol. 1996;29:345-354.
5. Bongiovanni M, Viberti L, Pecchioni C, et al. Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells. J Pathol. 2002;198:252-257.
6. Bostwick DG, Hossain D, Qian J, et al. Phyllodes tumor of the prostate: long-term followup study of 23 cases. J Urol. 2004;172:894-899.
7. Brolin J, Skoog L, Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate. 1992;20:281-295.
8. Byrne RL, Leung H, Neal DE. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol. 1996;77:627-633.
9. Fisher C, Goldblum JR, Epstein JI, et al. Leiomyosarcoma of the paratesticular region: a clinicopathologic study. Am J Surg Pathol. 2001;25:1143-1149.
10. Gaudin PB, Rosai J, Epstein JI. Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases. Am J Surg Pathol. 1998;22:148-162.
11. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580.
12. Kerley SW, Pierce P, Thomas J. Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma. Arch Pathol Lab Med. 1992;116:195-197.
13. Kevwitch MK, Walloch JL, Waters WB, et al. Prostatic cystic epithelial-stromal tumors: a report of 2 new cases. J Urol. 1993;149:860-864.
14. Kuhnen C, Herter P, Muller O, et al. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol. 2000;13:1005-1013.
15. Lee C. Role of androgen in prostate growth and regression: stromal-epithelial interaction. Prostate. 1996;28(Suppl 6):52-58.
16. Leong SS, Vogt PJ, Yu GSM. Atypical stromal smooth muscle hyperplasia of prostate. Urology. 1988;31:163-167.
17. Manivel C, Shenoy BV, Wick MR, et al. Cystosarcoma phyllodes of the prostate. A pathologic and immunohistochemical study. Arch Pathol Lab Med. 1986;110:534-538.
18. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25:1121-1133.
19. Mobbs BG, Liu Y. Immunohistochemical localization of progesterone receptor in benign and malignant human prostate. Prostate. 1990;16:245-251.
20. Natali PG, Nicotra MR, Sures I, et al. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 1992;52:6139-6143.
21. Niu Y, Xu Y, Zhang J, et al. Proliferation and differentiation of prostatic stromal cells. BJU Int. 2001;87:386-393.
22. Paal E, Miettinen M. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Pathol. 2001;25:1355-1363.
23. Smith P, Rhodes NP, Ke Y, et al. Modulating effect of estrogen and testosterone on prostatic stromal cell phenotype differentiation induced by noradrenaline and doxazosin. Prostate. 2000;44:111-117.
24. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol. 1998;22:863-872.
25. Watanabe M, Yamada Y, Kato H, et al. Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection. Pathol Int. 2002;52:777-783.
26. Wisniewski D, Lambek CL, Liu C, et al. Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Res. 2002;62:4244-4255.
27. Young RH, Scully RE. Pseudosarcomatous lesions of the urinary bladder, prostate gland, and urethra. Arch Pathol Lab Med. 1987;111:354-358.